Wordt geladen...
Combination of guanine arabinoside and Bcl‐2 inhibitor YC137 overcomes the cytarabine resistance in HL‐60 leukemia cell line
Cytarabine (ara‐C) is the key agent for treating acute myeloid leukemia. After being transported into leukemic cells, ara‐C is phosphorylated, by several enzymes including deoxycytidine kinase (dCK), to ara‐C triphosphate (ara‐CTP), an active metabolite, and then incorporated into DNA, thereby inhib...
Bewaard in:
| Gepubliceerd in: | Cancer Sci |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7657161/ https://ncbi.nlm.nih.gov/pubmed/23320492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12103 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|